Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.53 USD | +2.65% | +4.62% | -33.36% |
04-09 | Synaptogenix, Inc. acquired Unknown Stake in Psyga Bio Ltd from Cannasoul Analytics Ltd. | CI |
04-03 | Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall | MT |
Sales 2022 | - | Sales 2023 | - | Capitalization | 5.54M 444M |
---|---|---|---|---|---|
Net income 2022 | -5M -400M | Net income 2023 | -6M -480M | EV / Sales 2022 | - |
Net cash position 2022 | 37.48M 3B | Net cash position 2023 | 30.1M 2.41B | EV / Sales 2023 | - |
P/E ratio 2022 |
-1.42
x | P/E ratio 2023 |
-0.23
x | Employees | 5 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 97.57% |
1 day | +2.65% | ||
1 week | +4.62% | ||
Current month | -3.36% | ||
1 month | -8.48% | ||
3 months | -9.22% | ||
6 months | -37.50% | ||
Current year | -33.36% |
Managers | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 31/12/17 |
Daniel Alkon
PSD | President | 81 | 06/12/20 |
Robert Weinstein
DFI | Director of Finance/CFO | 64 | 31/05/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Tuchman
CEO | Chief Executive Officer | 77 | 31/12/17 |
Bruce Bernstein
BRD | Director/Board Member | 60 | 13/11/16 |
Joshua Silverman
CHM | Chairman | 53 | 03/08/16 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 4.53 | +2.65% | 6,926 |
25/04/24 | 4.413 | -3.22% | 3,503 |
24/04/24 | 4.56 | -0.22% | 14,442 |
23/04/24 | 4.57 | +4.82% | 40,601 |
22/04/24 | 4.36 | +0.69% | 53,626 |
Delayed Quote Nasdaq, April 26, 2024 at 09:30 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-33.36% | 4.92M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SNPX Stock